Cargando…

Mechanism of traditional Chinese medicine in treating overactive bladder

Overactive bladder syndrome (OAB) has made increasing progress in mechanism and treatment research. Traditional Chinese medicine (TCM) is a common complementary therapy for OAB, and it has been found to be effective. However, the intervention mechanism of TCM in the treatment of OAB is still unclear...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liao, Yuxiang, Du, Xin, Fu, Yuanbo, Liu, Lu, Wei, Jiangyan, An, Qi, Luo, Xuanzhi, Gao, Fan, Jia, Shuhan, Chang, Ying, Guo, Mengxi, Liu, Huilin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2022
Materias:	Urology - Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9957912/ https://www.ncbi.nlm.nih.gov/pubmed/36479677 http://dx.doi.org/10.1007/s11255-022-03434-8

Ejemplares similares

Impact of depression on overactive bladder
por: Kawahara, Takashi, et al.
Publicado: (2020)

Potential benefits of diagnosis and treatment on health outcomes among elderly people with symptoms of overactive bladder
por: Lee, L. K., et al.
Publicado: (2015)

OnabotulinumtoxinA 100U provides significant improvements in overactive bladder symptoms in patients with urinary incontinence regardless of the number of anticholinergic therapies used or reason for inadequate management of overactive bladder
por: Sievert, K-D, et al.
Publicado: (2014)

Comparative assessment of onabotulinumtoxinA and mirabegron for overactive bladder: an indirect treatment comparison
por: Freemantle, Nick, et al.
Publicado: (2016)

Risk factors associated with the progression of overactive bladder among patients with type 2 diabetes
por: Zhu, Yiyi, et al.
Publicado: (2019)

Effects of flexible-dose fesoterodine on overactive bladder symptoms and treatment satisfaction: an open-label study
por: Wyndaele, J-J, et al.
Publicado: (2009)

Practical aspects of lifestyle modifications and behavioural interventions in the treatment of overactive bladder and urgency urinary incontinence
por: Wyman, J F, et al.
Publicado: (2009)

Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add‐on mirabegron therapy to solifenacin (BESIDE)
por: Drake, Marcus J., et al.
Publicado: (2017)

A novel approach to overactive bladder syndrome treatment
por: Szalecki, Paweł
Publicado: (2014)

Efficacy and safety of fesoterodine 8 mg in subjects with overactive bladder after a suboptimal response to tolterodine ER
por: Kaplan, S A, et al.
Publicado: (2014)

Adherence and persistence of mirabegron and anticholinergic therapies in patients with overactive bladder: a real‐world claims data analysis
por: Sussman, D., et al.
Publicado: (2017)

Real-world persistence and adherence to oral antimuscarinics and mirabegron in patients with overactive bladder (OAB): a systematic literature review
por: Yeowell, Gillian, et al.
Publicado: (2018)

Relationship between overactive bladder and irritable bowel syndrome: a large-scale internet survey in Japan using the overactive bladder symptom score and Rome III criteria
por: Matsumoto, Seiji, et al.
Publicado: (2013)

Sleep disturbance changes in women after treatment of refractory overactive bladder with sacral neuromodulation
por: Sanderson, Derrick J., et al.
Publicado: (2020)

Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase III studies
por: Nitti, V W, et al.
Publicado: (2013)

Predictive Factors for High Post-void Residual Volume in Older Females After OnabotulinumA Treatment for Severe Overactive Bladder Using a Machine Learning Model
por: Okui, Nobuo, et al.
Publicado: (2023)

Editorial Comment: Combination therapy in overactive bladder-untapped research opportunities: A systematic review of the literature
por: Riccetto, Cássio L. Z.
Publicado: (2021)

Acupuncture for Women with Overactive Bladder: Perspective of Traditional Chinese Medicine and Related Mechanism
por: Wang, Hao, et al.
Publicado: (2023)

Clinical and Economic Evaluation of Transdermal Oxybutynin in the Treatment of Overactive Bladder in Spain
por: Crespo, Carlos, et al.
Publicado: (2018)

Friction underwear for ease of pulling down in elderly patients with overactive bladder: A prospective randomized control trial
por: You, Jae Hyung, et al.
Publicado: (2019)

Editorial Comment: Increased risk of dementia among patients with overactive bladder treated with an anticholinergic medication compared to a beta-3 agonist: a population-based cohort study
por: Moreno-Palacios, Jorge
Publicado: (2021)

Efficacy and safety of intradetrusor onabotulinumtoxinA injection for managing paediatric non-neurogenic overactive bladder: A prospective case-series study
por: El-Dakhakhny, Amr S., et al.
Publicado: (2019)

Elicitation of Health-related Quality-of-life Concepts Associated with Overactive Bladder: A Qualitative Study
por: Hawken, Natalia, et al.
Publicado: (2016)

Posterior tibial nerve stimulation as treatment for the overactive bladder
por: Sherif, Hammouda, et al.
Publicado: (2013)

Validation of the Arabic linguistic version of the Overactive Bladder Symptoms Score questionnaire
por: Elbaset, M. A., et al.
Publicado: (2019)

A Case of Primary Lymphoepithelioma-Like Carcinoma of the Bladder With Review
por: Zheng, Gangfu, et al.
Publicado: (2023)

Home-based transcutaneous tibial nerve stimulation for overactive bladder syndrome: a randomized, controlled study
por: Cava, Robert, et al.
Publicado: (2022)

Significant Tumor Reduction With Traditional Chinese Medicine in a Patient With Advanced Prostate Cancer: A Case Report
por: Zhang, Xiaojun
Publicado: (2022)

Congenital bladder diverticulum with benign bladder wall lesion resembling rhabdomyosarcoma
por: Mak, David K-C, et al.
Publicado: (2010)

Prognostic value of ki67 in BCG-treated non-muscle invasive bladder cancer: a meta-analysis and systematic review
por: He, Yuhui, et al.
Publicado: (2018)

Treatment Patterns for Patients on Overactive Bladder Therapy: A Retrospective Statistical Analysis Using Canadian Claims Data
por: Wagg, Adrian, et al.
Publicado: (2016)

Cohort profile: The Swedish National Register of Urinary Bladder Cancer (SNRUBC) and the Bladder Cancer Data Base Sweden (BladderBaSe)
por: Häggström, Christel, et al.
Publicado: (2017)

300 IU vs. 200 IU of OnabotulinumtoxinA for detrusor overactivity
por: Persu, Cristian
Publicado: (2014)

Cohort profile: Bladder Cancer Data Base Sweden (BladderBaSe) 2.0
por: Häggström, Christel, et al.
Publicado: (2022)

TASCI—transcutaneous tibial nerve stimulation in patients with acute spinal cord injury to prevent neurogenic detrusor overactivity: protocol for a nationwide, randomised, sham-controlled, double-blind clinical trial
por: Birkhäuser, Veronika, et al.
Publicado: (2020)

Study protocol of a multicentre double-blind RCT, comparing a traditional RCT with an aggregated N-of-1 trial: GAG therapy Efficacy Trial Solution for Bladder pain syndrome/Interstitial cystitis (GETSBI study)
por: van Ginkel, Charlotte, et al.
Publicado: (2023)

Protocol for a phase II, open-label exploratory study investigating the efficacy of fesoterodine for treatment of adult patients with spinal cord injury suffering from neurogenic detrusor overactivity for amelioration of autonomic dysreflexia
por: Walter, Matthias, et al.
Publicado: (2018)

Idiopathic Pneumatosis of Small Bowel and Bladder
por: Gupta, Anupam K, et al.
Publicado: (2020)

A Rare Case of Bladder Perineurioma
por: Ferraz de Arruda, Germano José, et al.
Publicado: (2022)

Limited Value of Bladder Wash Cytology During Follow-Up of Patients With Non-muscle Invasive Bladder Cancer
por: Bieri, Uwe, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fvi5qj7728be5hb9kdtc33cjh8